nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Author index
|
|
|
2001 |
20 |
4 |
p. 275- 1 p. |
artikel |
2 |
Introduction
|
Eichenfield, Lawrence F. |
|
2001 |
20 |
4 |
p. 215-216 2 p. |
artikel |
3 |
Pathophysiologic mechanisms in atopic dermatitis
|
Boguniewicz, Mark |
|
2001 |
20 |
4 |
p. 217-225 9 p. |
artikel |
4 |
Pimecrolimus cream 1%: A new development in nonsteroid topical treatment of inflammatory skin diseases
|
Hebert, Adelaide A. |
|
2001 |
20 |
4 |
p. 260-267 8 p. |
artikel |
5 |
Pimecrolimus (Elidel, SDZ ASM 981)—Preclinical pharmacologic profile and skin selectivity
|
Stuetz, Anton |
|
2001 |
20 |
4 |
p. 233-241 9 p. |
artikel |
6 |
Safety of the new macrolide immunomodulators
|
Robinson, Neha |
|
2001 |
20 |
4 |
p. 242-249 8 p. |
artikel |
7 |
Subject index
|
|
|
2001 |
20 |
4 |
p. 275-281 7 p. |
artikel |
8 |
Tacrolimus clinical studies for atopic dermatitis and other conditions
|
Bergman, James |
|
2001 |
20 |
4 |
p. 250-259 10 p. |
artikel |
9 |
Tacrolimus pharmacology and nonclinical studies: From FK506 to protopic
|
Bekersky, Ihor |
|
2001 |
20 |
4 |
p. 226-232 7 p. |
artikel |
10 |
Topical tacrolimus and pimecrolimus: Future directions
|
Ling, Mark R. |
|
2001 |
20 |
4 |
p. 268-274 7 p. |
artikel |